LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Lung adenocarcinoma patient with an EGFR kinase domain duplication (KDD) and the response to icotinib.

Photo by lunarts from unsplash

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide (1). Epidermal growth factor receptor ( EGFR ) mutations, as driver oncogenes, were first identified… Click to show full abstract

Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related morbidity and mortality worldwide (1). Epidermal growth factor receptor ( EGFR ) mutations, as driver oncogenes, were first identified in NSCLC in 2004 (2).

Keywords: lung adenocarcinoma; adenocarcinoma patient; patient egfr; kinase domain; egfr kinase; lung

Journal Title: Journal of thoracic disease
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.